Conference Proceedings

All-Oral Treatment With Daclatasvir (DCV) Plus Sofosbuvir (SOF) Plus Ribavirin (RBV) for 12 or 16 Weeks in HCV Genotype (GT) 3-Infected Patients With Advanced Fibrosis or Cirrhosis: The ALLY-3 Phase 3 Study

Vincent Leroy, Peter W Angus, Jean-Pierre Bronowicki, Gregory Dore, Christophe Hezode, Stephen Pianko, Stanislas Pol, Katherine A Stuart, Edmund Tse, Fiona McPhee, Rafia Bhore, Maria Jesus Jimenez Exposito, Alex J Thompson

HEPATOLOGY | WILEY-BLACKWELL | Published : 2015